GPT Healthcare Ltd

GPT Healthcare Ltd

GPT Healthcare Ltd has scheduled a Board Meeting on November 5, 2026, to consider and approve the Unaudited Financial Results for the 2nd quarter and half year ended on September 30, 2026, and to declare an interim dividend for FY 2026-27.

GPT Healthcare Ltd

GPT Healthcare Ltd has appointed Cygnus Partners Private Limited as its Investor Relations Agency to strengthen investor communication, enhance transparency, and improve visibility in the capital markets.

GPT Healthcare Ltd

GPT Healthcare Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming no dematerialization or rematerialization requests were received for the quarter ended September 30, 2026.

GPT Healthcare Ltd

GPT Healthcare Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the 2nd quarter and half year ending on September 30, 2026.

GPT Healthcare Ltd

GPT Healthcare Ltd has released its Q1FY27 earnings call transcript, highlighting an 18.2% increase in total income and a 66% increase in PAT compared to the same period last year. The company's network occupancy stood at 45.5%, with average revenue per occupied bed (ARPOB) improving to INR42,350.

GPT Healthcare Ltd

GPT Healthcare Ltd has announced the voting results and scrutinizer's report of its 37th Annual General Meeting held on August 6, 2026. All resolutions were passed with the requisite majority.

GPT Healthcare Ltd

GPT Healthcare Ltd held its 37th Annual General Meeting on August 6, 2026, through video conferencing, with 66 members holding 65.60% shares attending the meeting. The meeting was conducted in compliance with the latest General Circular No. 03/2025 issued by the Ministry of Corporate Affairs.

GPT Healthcare Ltd

GPT Healthcare Ltd has released an audio recording of a conference call discussing its un-audited financial results for the 1st quarter ended June 30, 2026. The meeting was held on August 4, 2026, and no unpublished price-sensitive information was shared.

GPT Healthcare Ltd

GPT Healthcare Ltd has announced the publication of its unaudited financial results for the 1st quarter ended June 30, 2026, in compliance with SEBI regulations. The company has also announced the 15th Annual General Meeting (AGM) to be held on August 27, 2026, and has provided details on remote e-voting and e-proxy facilities.

GPT Healthcare Ltd

GPT Healthcare Limited reported unaudited financial results for Q1FY27, with total income at Rs 128 crore, a growth of 18% y-o-y. EBITDA and PAT stood at Rs 26.2 crore and Rs 12.7 crore, respectively. The company maintained a competitive ARPOB and recorded steady improvement in occupancy rates. Key operational highlights included the completion of over 700+ renal transplants, launch of robotic knee surgery programme, and delivery of over 700 radiation therapy procedures.

GPT Healthcare Ltd

GPT Healthcare Ltd has submitted an investor presentation on its un-audited financial results for Q1FY2027, showing healthy operational performance with an increase in average revenue per occupied bed (ARPOB) to ₹42350 driven by improved clinical mix and operating efficiencies.

GPT Healthcare Ltd

GPT Healthcare Ltd has announced its unaudited financial results for Q1FY2027, with revenue from operations at ₹12,620.43 lakhs and total income at ₹12,823.04 lakhs.

GPT Healthcare Ltd

GPT Healthcare Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹12,620.43 lakhs and total income at ₹12,823.04 lakhs.

GPT Healthcare Ltd

GPT Healthcare Ltd has scheduled an earnings call on August 4, 2026, to discuss its un-audited financial results for the first quarter ended June 30, 2026.

GPT Healthcare Ltd

GPT Healthcare Ltd has scheduled a Board Meeting on August 3, 2026, to consider and approve the unaudited financial results for the 1st quarter ended June 30, 2026, along with the limited review report of the statutory auditor.